Markets

News Details

( 10/01/2018 12:09)
Aurobindo Pharma - Investor Grievance Report For The Quarter Ended 31.12.2017

Pursuant to Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, we furnish hereunder the Investor Grievance Report for the Quarter ended 31.12.2017.

Scores Registration No. --- A00384

No. of Investor complaints pending at the beginning of the quarter --- Nil

No. of Investor complaints received during the quarter --- 5

No. of Investor complaints disposed off during the quarter --- 5

No. of Investor complaints pending un-resolved at the end of the quarter --- Nil

ATTENTION INVESTORS "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case

SEBI Regn. NSE: INB231280430 I F&O: INF231280430 I BSE: INB011280436 I NSE CD: INE231280430 I MCX-SX: INE261280430

Copyright © 2017 Rikhav Securities Ltd. All rights reserved

Designed , Developed & Content Powered by DION